Cargando…
Effects of SB202190 on expression levels of IL-6 and NF-κB in flap ischemia-reperfusion injury
The aim of the current study was to investigate the effect of SB202190, a specific inhibitor of p38 MAPK signaling pathway, on the expression levels of IL-6 and NF-κB in flap ischemia-reperfusion injury. Healthy Sprague-Dawley rats were randomly divided into four groups of 12 each. For the ischemia-...
Autores principales: | Guo, Kai, Ma, Jingxin, Liang, Wenyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122530/ https://www.ncbi.nlm.nih.gov/pubmed/30210603 http://dx.doi.org/10.3892/etm.2018.6442 |
Ejemplares similares
-
In Vitro Effects of SB202190 on Echinococcus granulosus
por: Lv, Hailong, et al.
Publicado: (2013) -
A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190
por: Glover, Mark, et al.
Publicado: (2010) -
SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase-1
por: Schwartz, Margit, et al.
Publicado: (2018) -
PERK activation by SB202190 ameliorates amyloidogenesis via the TFEB-induced autophagy-lysosomal pathway
por: Do, Mihyang, et al.
Publicado: (2022) -
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation
por: Costa, Delfina, et al.
Publicado: (2023)